Fertility sparing treatment in cervical cancer management in pregnancy

Michael J. Halaska, Vit Drochytek, Roman G. Shmakov, Frédéric Amant

Research output: Contribution to journalReview articleAcademicpeer-review

3 Citations (Scopus)

Abstract

The article focuses on fertility-sparing management during pregnancy and obstetrical management after fertility-sparing surgery. Over the years, more women in developed countries tend to delay childbirth to a later age, which leads to cervical cancer more often diagnosed during pregnancy. The advances in our understanding of prognosis and treatment options in these patients have helped us to address avenues and to circumvent standard therapy and fetal demise, respecting maternal and fetal chances. Childbearing trends also lead to an increase in the number of patients considering fertility-sparing management when diagnosed with cervical cancer. Such management represents a challenge for obstetricians as prior cervical surgery is a known risk factor for various adverse events. These include decreased fertility, second trimester miscarriage, preterm labor, or preterm premature rupture of membranes. Watchful follow-up and various prophylactic measures are keys when striving for the best possible outcome.
Original languageEnglish
Pages (from-to)101-112
Number of pages12
JournalBest practice & research. Clinical obstetrics & gynaecology
Volume75
Early online date2021
DOIs
Publication statusPublished - Sept 2021

Keywords

  • Cervical cancer
  • Management
  • Neoadjuvant chemotherapy
  • Obstetrical management
  • Pregnancy

Cite this